Author: BIOtechNOW Editor
Start-Up CEO: Making the Choices to Develop a Novel Medicine
The choices surrounding research investment and drug development are daunting for even the most experienced …
“High Tech Enables High Touch.” Stanford’s Dean of Medicine on How Technology is Changing the ...
Dean Lloyd Minor says technology, and specifically, smartphones are making healthcare deliverable in real-time. By …
100 Breakthrough Cancer Inventions from 100 Companies? BIO and CAI are Betting On It
There are more than 150,000 inventions that are “sitting on the shelf – because of …
New EDC Research Cracks the Code of the San Diego Genomics Industry
A news conference followed by a panel discussion with local experts today released the first …
A Patient Advocate Perspective on BIO
As the mother of a 12-year-old son with hypophosphatasia, the BIO International Convention is much …
The Sarcoma Foundation of America, a Patient Advocacy Group for a Rare Cancer
The Sarcoma Foundation of America (SFA) is national cancer research non-profit headquartered in Maryland. Founded …
Taking on High-Risk Investments to Understand Brains and Solve Epilepsy
30 percent of people living with epilepsy do not have seizure control. Moreover, many can …
Why Shared Services Will Change Biopharma Forever
The mission statement for most biopharmaceutical companies is to bring lifesaving therapies to patients anywhere …
New Resource Center – One-Stop for All Things Lupus
A keen understanding of the education and support needs of all those impacted by lupus …
BIO World Congress Agenda Shows Industrial Biotech Diversifying, Differentiating, Disrupting, Disint...
This July, industrial biotech returns to its largest and grandest stage at the BIO World …